Close

Wenzel Spine Announces Acquisition of Statera Spine

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...

Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, announced that it has completed the acquisition of Statera Spine, a pre-operative diagnostics and quantitative data software solution that improves treatment decisions for spine patients.

Statera Spine is a software enabled spine imaging analytics company dedicated to providing easy-to-use solutions that facilitate improved care for patients suffering from chronic and acute spine issues. Standard pre-operative imaging does not allow for consideration of overall spine biomechanics, including sagittal alignment. The ProfileESP (Expanded Spine Parameters Report), VMA (Vertebral Motion Analysis) technology and integrated Surgical Planning Solution will enhance Wenzel’s current spine fusion-related product portfolio by providing vital diagnostic and decision-making tools that are missing from today’s technology.

“Solutions in diagnostics and surgical planning tools play a critical role in the advancement of Wenzel Spine’s total solution offering in minimally invasive surgery,” said Chad Neely, CEO of Wenzel Spine. “We are very excited to have the experience, expertise and dedication of the Statera Spine team as part of Wenzel Spine. The addition of these unique diagnostic and planning solutions complement our existing minimally invasive implant technology and allow us to bring comprehensive solutions to spine surgeons and their patients. By combining diagnostics with our MIS implant portfolio, we can continue to advance minimally invasive spine surgery, while reducing overall cost.”

The new Wenzel Spine Diagnostics service offering will allow physicians to utilize full spine alignment data, plus motion (angulation and translation) and disc height data at each spine level to aid in the decision-making process alongside their patients. The diagnostic service results in standardized, comprehensive spinal motion and alignment data is conveniently packaged in a graphical, easy-to-read report. Profile ESP and VMA are commercially available in the US. The Surgical Planning Solution is planned to be launched and commercially available in the US in early 2021.

About Wenzel Spine, Inc.

Wenzel Spine, Inc. is a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders. Headquartered in Austin, TX, Wenzel Spine is focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. Wenzel Spine seeks to improve patient quality of life by designing and producing devices of the highest quality to support our surgeon clients in the care and treatment of their patients.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back